• Home
  • Cutaneous CD56+ T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma.

Cutaneous CD56+ T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma.

Author List
Zheng YJ, Lee A, Pincus L, Ho W, Vujic M, Ortiz-Urda S
Publication
JAAD case reports
Publication ID (Profile URL)
https://researcherprofiles.org/profile/14389349
Publication Year
2018
PubMed ID
29892669
Publication Title
Zheng YJ, Lee A, Pincus L, Ho W, Vujic M, Ortiz-Urda S. Cutaneous CD56+ T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma. JAAD Case Rep. 2018 Jul; 4(6):540-542.